Yatırımcı.AI

TRILC vs RGYAS Comparison

Price, market cap, valuation, profitability and leverage metrics of TRILC and RGYAS side by side.

TRILCRGYAS
StockFund

If You Had Invested TRY 10,000

Metric Comparison

TRILC vs RGYAS Comparison
MetricTRILCRGYASSector median
Last price (TL)0.90189.1018.72
Daily change0.00%−2.43%−5.66%
Market capTRY 933.3MTRY 62.6BTRY 4.3B
P/E—2.8917.25
P/B0.470.391.08
Dividend yield—1.15%0.90%
Return on equity−4.59%15.39%1.78%
Free float73.16%27.19%37.21%
Ratios are calculated from the latest published financial statements.

Popular Comparisons

Related Pages

About the TRILC vs RGYAS Comparison

Price, market cap, valuation multiples, profitability and leverage of TRILC (Türk İlaç Serum) and RGYAS (Ronesans Gayrimenkul Yat.) side by side as of Sep 28, 2026, 14:00. Of the 13 metrics compared, TRILC leads in 4 and RGYAS leads in 9.

Highlights: Daily change: TRILC leads (0.00% vs −2.43%). Market cap: RGYAS leads (TRY 62.6B vs TRY 933.3M). P/B: RGYAS leads (0.39 vs 0.47). EV/EBITDA: TRILC leads (3.67 vs 8.66). EV/Sales: TRILC leads (3.61 vs 9.61). Gross margin: RGYAS leads (70.91% vs 25.29%). EBITDA margin (annual): TRILC leads (27.80% vs 4.17%). Net margin (annual): RGYAS leads (147.56% vs −1.65%).

Frequently Asked Questions

By P/E, Tie is cheaper (— vs 2.89); by P/B, RGYAS trades at the lower multiple (0.47 vs 0.39).

Annual net margin is −1.65% for TRILC and 147.56% for RGYAS; return on equity is −4.59% for TRILC and 15.39% for RGYAS.

The leverage ratio is 76.53 for TRILC and 31.40 for RGYAS; net debt/EBITDA is 2.88 for TRILC and — for RGYAS. Lower values mean less leverage.

Prices and market caps come from 15-minute delayed Borsa Istanbul data; ratios are calculated from the latest financial statements filed with KAP. Some ratios are not defined for banks and insurers.